Please provide your email address to receive an email when new articles are posted on . Adults with diabetes receiving both basal and bolus insulin through a smart pen miss about six doses every 14 ...
Researchers observed a decrease in mean HbA1c from baseline to week 52 from 8.20 to 7.05% with efsitora and from 8.28 to 7.08% with glargine. HealthDay News — Once-weekly insulin efsitora alpha ...
ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
Rate of combined clinically significant or severe hypoglycemia significantly lower with efsitora versus glargine. (HealthDay News) — Once-weekly insulin efsitora alpha (efsitora) is noninferior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results